Research Programs | UC Davis MIND Institute

Developmental-behavioral pediatrician Kathy Angkustsiri leads a team that studies the developmental and behavioral characteristics of various neurodevelopmental disabilities. These include chromosome 22q11.2 deletion syndrome, Down syndrome and autism. Current studies include evaluating the use of stimulant medication in children with Down syndrome who also have ADHD.

This program works to improve the lives of children, teens and adults experiencing challenges with attention, impulsivity, or cognitive and emotional regulation. This includes helping people with attention deficit/hyperactivity disorder (ADHD), vulnerability for substance use and problems with self-regulation. Areas of research include brain function and development in ADHD, virtual reality treatment for improving attention and testing links between fidgeting and attention. The program is directed by Julie Schweitzer, professor in the Department of Psychiatry and Behavioral Sciences. The program’s clinic director is licensed clinical psychologist J. Faye Dixon.

The Collaborative START lab aims to improve the quality of life of autistic people and their families by improving access to high quality education and treatment through translation of evidence-based treatment into effective, publicly funded community services that reach traditionally underserved populations.

This lab, led by Professor of Psychiatry and Behavioral Sciences Sally Ozonoff, studies how to identify autism as early in childhood as possible. Early identification of autism helps children get services when they are most beneficial. Our current work explores the use of telehealth assessments and online screeners to improve early detection and access to diagnostic services for families in underserved communities.

This program is directed by Randi Hagerman, developmental-behavioral pediatrician and world-renowned fragile X researcher, and provides comprehensive clinical services, including psychological testing and medical assessment. The multidisciplinary program includes specialist in pediatrics, molecular genetics, psychiatry, psychology, neurology, neurobiology, pathology and social work. Researchers conduct a wide variety of studies that advance understanding of fragile X-related conditions and treatment.

This research lab, led by former MIND Institute director Leonard Abbeduto, is trying to understand how language develops in children who have certain developmental disabilities like fragile X syndrome, Down syndrome and autism. Researchers have noticed that each condition has its own unique characteristics when it comes to language, with different areas where children may do well or struggle.

Led by Associate Professor of Psychiatry and Behavioral Sciences Meghan Miller, the goal of this lab is to uncover early signs of autism and ADHD in infants and toddlers, and to better understand the links between these two conditions. They closely track the development of infants and toddlers to gain a better understanding of their attention skills, emotion regulation, self-control, and social and communication skills over the first few years of life.

By participating in or studies, your family will contribute to a better understanding of how our environment can be improved in schools, communities, and homes to improve children’s lives: their achievements, their relationships with others, and their health.

This lab, led by MIND Institute Interim Director Marjorie Solomon, uses cognitive neuroscience methods to advance the study of higher cognition in autism. One aspect of this research focuses on cognitive control — the ability to flexibly allocate mental resources to guide thoughts and actions in light of internal goals. Researchers use neuroimaging to study brain activity and patterns from adolescence through young adulthood. The Solomon lab also studies learning memory in this same age group.

This lab, called T-PAL (Translational Psychophysiology and Assessment Laboratory), focuses on understanding how genes, the brain, and behavior are connected in neurodevelopmental disabilities, particularly in conditions related to fragile X syndrome. Current studies include long-term research into possible biomarkers for FXTAS (fragile X-associated tremor/ataxia syndrome) and the investigation of a smartphone-based app as a way for parents to report ADHD symptoms and behavior in children with neurodevelopmental conditions. David Hessl, professor in the Department of Psychiatry and Behavioral Sciences runs T-PAL.

CENE collects brains from patients diagnosed with autism, fragile X Syndrome, Down syndrome and other neurodevelopmental disabilities. Our program also performs research, promotes education, and enhances public awareness about the importance of human tissue availability for scientific research on brain function.